Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. (trading symbol: EYES) on July 7, 2020. The report details a material definitive agreement entered into on the same date regarding the company's primary facility in Sylmar, California.
Key Financial Metrics and Material Changes
The filing reports a significant reduction in operating lease costs effective June 16, 2020.
- New Monthly Rent: $15,931.80 (inclusive of a proportionate share of maintenance costs).
- Prior Monthly Rent: $37,662.76 (plus maintenance costs averaging approximately $20,000 per month in 2019).
- Lease Term: June 16, 2020, through December 31, 2020, with automatic monthly renewal unless terminated with 30 days' notice.
- Operational Impact: The company is leasing a smaller portion of its current facility to reduce costs while maintaining its address and supporting current staff and operations.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics.
Outlook, Risks, and Management Commentary
Management confirmed that the downsized facility will continue to support the company's Orion early feasibility study, which involves six subjects at UCLA and Baylor College of Medicine, as well as other Orion research activities. The primary strategic objective of this agreement is cost reduction.
Investor Verification Checklist
- Verify the exact square footage reduction and the specific terms of the "proportionate share" of maintenance costs in the new lease.
- Confirm the status and enrollment progress of the Orion early feasibility study at UCLA and Baylor College of Medicine.
- Review subsequent filings for any further cost-cutting measures or changes in operational capacity.
- Check the company's cash runway given the reduced burn rate from the lease savings.